Alexandre Storto

793 total citations
24 papers, 448 citations indexed

About

Alexandre Storto is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Alexandre Storto has authored 24 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 21 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Alexandre Storto's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (21 papers) and HIV/AIDS Research and Interventions (11 papers). Alexandre Storto is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (21 papers) and HIV/AIDS Research and Interventions (11 papers). Alexandre Storto collaborates with scholars based in France, Italy and United Kingdom. Alexandre Storto's co-authors include Diane Descamps, Benoît Visseaux, Anne‐Geneviève Marcelin, Diane Descamps, Vincent Cálvez, Gilles Collin, Françoise Brun‐Vézinet, Florence Damond, Lucile Larrouy and Charlotte Charpentier and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Alexandre Storto

24 papers receiving 444 citations

Peers

Alexandre Storto
Alexandre Storto
Citations per year, relative to Alexandre Storto Alexandre Storto (= 1×) peers Nicholas Bbosa

Countries citing papers authored by Alexandre Storto

Since Specialization
Citations

This map shows the geographic impact of Alexandre Storto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Storto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Storto more than expected).

Fields of papers citing papers by Alexandre Storto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Storto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Storto. The network helps show where Alexandre Storto may publish in the future.

Co-authorship network of co-authors of Alexandre Storto

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Storto. A scholar is included among the top collaborators of Alexandre Storto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Storto. Alexandre Storto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schramm, Birgit, Elvis Temfack, Diane Descamps, et al.. (2022). Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study. The Lancet HIV. 9(8). e544–e553. 48 indexed citations
2.
Martin, Alexandra, Alexandre Storto, Quentin Le Hingrat, et al.. (2021). High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings. Journal of Clinical Virology. 141. 104895–104895. 10 indexed citations
3.
Lebourgeois, Samuel, Alexandre Storto, Bernard Gout, et al.. (2021). Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. International Journal of Infectious Diseases. 107. 179–181. 12 indexed citations
4.
Charpentier, Charlotte, Alexandre Storto, Cathia Soulié, et al.. (2021). Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients. Journal of Antimicrobial Chemotherapy. 76(11). 2983–2987. 15 indexed citations
5.
Visseaux, Benoît, Quentin Le Hingrat, Gilles Collin, et al.. (2020). Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection. Journal of Clinical Virology. 129. 104520–104520. 39 indexed citations
6.
Hingrat, Quentin Le, Marine Perrier, Gilles Collin, et al.. (2018). Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads. Journal of Virological Methods. 257. 12–15. 1 indexed citations
7.
Perrier, Marine, Nathalie Désiré, Alexandre Storto, et al.. (2018). Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants. PLoS ONE. 13(6). e0198334–e0198334. 8 indexed citations
8.
Storto, Alexandre, Benoît Visseaux, Mélanie Bertine, et al.. (2017). Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients. Journal of Antimicrobial Chemotherapy. 73(5). 1173–1176. 3 indexed citations
9.
Bertine, Mélanie, Charlotte Charpentier, Benoît Visseaux, et al.. (2015). High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients. AIDS. 29(7). 779–784. 9 indexed citations
10.
Charpentier, Charlotte, Guinevere Q. Lee, Christophe Rodriguez, et al.. (2015). Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response. Journal of Antimicrobial Chemotherapy. 70(7). 2090–2096. 23 indexed citations
11.
Charpentier, C., Sidonie Lambert-Niclot, Benoît Visseaux, et al.. (2013). Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010. Journal of Antimicrobial Chemotherapy. 68(10). 2197–8. 12 indexed citations
12.
Lambert-Niclot, Sidonie, C. Charpentier, Alexandre Storto, et al.. (2013). Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 69(4). 1086–1089. 18 indexed citations
13.
Charpentier, Charlotte, Sidonie Lambert-Niclot, Claudia Alteri, et al.. (2013). Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes. PLoS ONE. 8(1). e54381–e54381. 2 indexed citations
14.
Lambert-Niclot, Sidonie, C. Charpentier, Alexandre Storto, et al.. (2013). Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses. Journal of Antimicrobial Chemotherapy. 68(6). 1237–1242. 36 indexed citations
15.
Charpentier, C., Lucile Larrouy, Benoît Visseaux, et al.. (2012). Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients. Journal of Antimicrobial Chemotherapy. 67(6). 1459–1461. 20 indexed citations
16.
Delelis, Olivier, Charlotte Charpentier, Alexandre Storto, et al.. (2011). G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to Raltegravir whereas Y143C does not. Retrovirology. 8(1). 68–68. 21 indexed citations
17.
Visseaux, Benoît, Margarita Hurtado-Nédelec, C. Charpentier, et al.. (2011). Molecular Determinants of HIV-2 R5-X4 Tropism in the V3 Loop: Development of a New Genotypic Tool. The Journal of Infectious Diseases. 205(1). 111–120. 26 indexed citations
18.
Visseaux, Benoît, Charlotte Charpentier, Margarita Hurtado-Nédelec, et al.. (2011). In VitroPhenotypic Susceptibility of HIV-2 Clinical Isolates to CCR5 Inhibitors. Antimicrobial Agents and Chemotherapy. 56(1). 137–139. 20 indexed citations
19.
Charpentier, Charlotte, Pantxika Bellecave, Mohamed Cissé, et al.. (2010). High Prevalence of Antiretroviral Drug Resistance among HIV-1-Untreated Patients in Guinea-Conakry and in Niger. Antiviral Therapy. 16(3). 429–433. 25 indexed citations
20.
Larrouy, Lucile, Corine Chazallon, Roland Landman, et al.. (2010). Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naive HIV-Infected Patients. Antimicrobial Agents and Chemotherapy. 54(7). 2910–2919. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026